Kirwan, Bridget-Anne

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 2,083

Sarcopenia with limited mobility: an international consensus

Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., Cederholm, T., Stewart Coats, A. J., Cummings, S. R., Evans, W. J., et al. (2011) · Journal of the American Medical Directors Association

Nutrition and Health in AgingFrailty in Older Adults

Cited by 1,125

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

Koehler, F., Koehler, K., Deckwart, O., Prescher, S., Wegscheider, K., Kirwan, B.-A., Winkler, S., Vettorazzi, E., Bruch, L., Oeff, M., et al. (2018) · The Lancet

Heart Failure Treatment and ManagementTelemedicine and Telehealth Implementation

Cited by 739

Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure: The Telemedical Interventional Monitoring in Heart Failure Study

Koehler, F., Winkler, S., Schieber, M., Sechtem, U., Stangl, K., Böhm, M., Boll, H., Baumann, G., Honold, M., Koehler, K., et al. (2011) · Circulation

Telemedicine and Telehealth ImplementationHeart Failure Treatment and Management

Cited by 716

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

Poole-Wilson, P. A., Lubsen, J., Kirwan, B.-A., van Dalen, F. J., Wagener, G., Danchin, N., Just, H., Fox, K. A., Pocock, S. J., Clayton, T. C., et al. (2004) · The Lancet

Heart rate and cardiovascular healthCoronary Interventions and Diagnostics

Cited by 511

Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial

Chiquet, C., Aptel, F., Creuzot-Garcher, C., Berrod, J.-P., Kodjikian, L., Massin, P., Deloche, C., Perino, J., Kirwan, B.-A., de Brouwer, S., et al. (2017) · American Journal of Ophthalmology

Ocular Infections and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 52

Subconjunctival Injection of XG-102, a JNK Inhibitor Peptide, in Patients with Intraocular Inflammation: A Safety and Tolerability Study

Beydoun, T., Deloche, C., Perino, J., Kirwan, B.-A., Combette, J.-M., & Behar-Cohen, F. (2015) · Journal of Ocular Pharmacology and Therapeutics

Ocular Diseases and Behçet’s SyndromeOcular Infections and Treatments

Cited by 39